4/9/2020  9:59:57 PM Chg. +1.10 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
85.98USD +1.30% 377,800
Turnover: 32.2 mill.
-Bid Size: - -Ask Size: - 151.73 bill.USD 1.53% 41.57

Business description

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 160 countries.
 

Management board & Supervisory board

CEO
Robert B. Ford
Management board
Robert E. Funck, Jr., Alejandro Wellisch, Andrea F. Wainer, Andrew H. Lane, Christopher J. Scoggins, Chuck Brynelsen, Corlis D. Murray, Daniel Salvadori, Dr. John M. Capek, Hubert L. Allen, J. Scott House, Jaime Contreras, Jared L. Watkin, John F. Ginascol, Joseph Manning, Lisa D. Earnhardt, Mary K. Moreland, Michael Dale, Michael J. Pederson, Randel Woodgrift, Robert Funck, Roger M. Bird, Sammy G. Karam
Supervisory board
Miles D. White, Daniel J. Starks, Darren W. McDew, Dr. Sally E. Blount, Edward M. Liddy, Glenn F. Tilton, John G. Stratton, Michelle A. Kumbier, Nancy McKinstry, Phebe N. Novakvic, Robert B. Ford, Robert J. Alpern, Roxanne S. Austin, Samuel C. Scott III, William A. Osborn
 

Company data

Name: Abbott Laboratories
Address: 100 Abbott Park Road,Abbott Park Illinois 60064-3500, USA
Phone: +1-847-937-6100
Fax: -
E-mail: -
Internet: www.abbott.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 78.00%
IPO date: -

Investor relations

Name: Scott Leinenweber
IR phone: +1-224-668-0791
IR Fax: -
IR e-mail: -

Main Shareholders

Freefloat
 
78.00%
The Vanguard Group
 
8.20%
Capital Research Global Investors
 
6.90%
BlackRock, Inc.
 
6.90%